Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Oral Semaglutide on Bone Turnover in Patients With Type 2 Diabetes: a Randomized Placebo-controlled Clinical Trial - (SOBER II)

NCT06050577 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06050577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06050577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Oral Semaglutide on Bone Turnover in Patients With Type 2 Diabetes: a Randomized Placebo-controlled Clinical Trial - (SOBER II)
Lead sponsor
Odense University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 7, 2024
Completion date
March 15, 2027
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia, type 2 diabetes